A new review of AI use in post-diagnosis breast cancer care shows most tools are designed for clinicians, with few patient-facing solutions and limited integration into real-world practice. The study ...

This valuable study presents a plastic recurrent spiking network model that spontaneously generates repeating neuronal sequences under unstructured inputs. The authors provide solid evidence that, ...

Actress Dipika Kakar recently underwent another surgery after a 1.3 cm cyst reoccurred near her liver. The relapse has come as an emotional setback for the actor, who has been undergoing treatment for ...

When bacteria enters into the bladder, it attaches onto proteins on the bladder wall, says Dr. Nseyo. “Certain women have proteins on their bladder walls that make them more likely to get recurrent ...

A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with higher recurrence risk after breast-conserving surgery. A Radiation ...

Short-course (3-month) enzalutamide monotherapy in biochemically recurrent prostate cancer (BCR): Preliminary prostate specific membrane antigen tumor volume (PSMA-TV) data. Anatomical location of ...

Dear Dr. Roach: About one year ago, I had Clostridioides difficile (C. diff) that was treated with 125 mg of vancomycin for about four weeks. I had none of the usual risk factors, and the cause was ...

The likelihood of EGFR-positive lung cancer returning is largely tied to how advanced it is when first diagnosed, with lower chances in early stages and higher odds in later stages. Newer targeted ...

ctDNA testing post-surgery identifies high-risk stage 3 colon cancer patients more accurately than traditional staging methods. Detectable ctDNA correlates with a four- to six-fold increased risk of ...

In a population-based cohort of 15- to 39-year-olds diagnosed with cancer, the risk for metastatic recurrence varied widely by cancer type and stage, and survival after recurrence was worse than after ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...